All Stories

  1. Chronic viral infection aggravates white adipose tissue dysfunction and liver pathology in obesity

    Article • Molecular Metabolism, August 2026, Elsevier

    Allan R Thomsen

  2. Systemic infection in aged mice causes upregulation of crystallin alpha A in the RPE/choroid

    Article • Experimental Eye Research, August 2024, Elsevier

    Allan R Thomsen

  3. Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

    Article • BMC Medicine, June 2024, Springer Science + Business Media

    Allan R Thomsen

  4. Vaccine induced memory CD8+ T cells efficiently prevent viral transmission from the respiratory tract

    Article • Frontiers in Immunology, December 2023, Frontiers

    Allan R Thomsen

  5. Prevention of respiratory virus transmission by resident memory CD8+ T cells

    Article • Nature, December 2023, Springer Science + Business Media

    Allan R Thomsen

  6. Molecular consequences of peripheral Influenza A infection on cell populations in the murine hypothalamus

    Article • eLife, September 2023, eLife

    Allan R Thomsen

  7. Systemic virus infection results in CD8 T cell recruitment to the retina in the absence of local virus infection

    Article • Frontiers in Immunology, August 2023, Frontiers

    Allan R Thomsen

  8. Molecular Consequences of Peripheral Influenza A Infection on Cell Populations in the Murine Hypothalamus

    Article • August 2023, eLife

    Allan R Thomsen

  9. Molecular Consequences of Peripheral Influenza A Infection on Cell Populations in the Murine Hypothalamus

    Article • May 2023, eLife

    Allan R Thomsen

  10. Molecular Consequences of Peripheral Influenza A Infection on Cell Populations in the Murine Hypothalamus

    Article • March 2023, Cold Spring Harbor Laboratory Press

    Allan R Thomsen

  11. Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade

    Article • OncoImmunology, December 2022, Taylor & Francis

    Allan R Thomsen

  12. A survey of mechanisms underlying current and potential COVID‐19 vaccines

    Article • Apmis, December 2022, Wiley

    Allan R Thomsen

  13. Persistent Antigen Harbored by Alveolar Macrophages Enhances the Maintenance of Lung-Resident Memory CD8+ T Cells

    Article • The Journal of Immunology, November 2022, Oxford University Press (OUP)

    Allan R Thomsen

  14. A Novel H-2d Epitope for Influenza A Polymerase Acidic Protein

    Article • Viruses, March 2022, MDPI AG

    Allan R Thomsen

  15. Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials

    Article • PLOS One, January 2022, PLOS

    Allan R Thomsen

  16. Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain

    Article • Viruses, November 2021, MDPI AG

    Allan R Thomsen

  17. Inter-vendor variance of enteric eukaryotic DNA viruses in specific pathogen free C57BL/6N mice

    Article • Research in Veterinary Science, May 2021, Elsevier

    Allan R Thomsen

  18. Functionally Competent, PD-1+ CD8+ Trm Cells Populate the Brain Following Local Antigen Encounter

    Article • Frontiers in Immunology, February 2021, Frontiers

    Allan R Thomsen

  19. Long-term maintenance of lung resident memory T cells is mediated by persistent antigen

    Article • Mucosal Immunology, January 2021, Elsevier

    Allan R Thomsen

  20. Vaccines to prevent COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING VACCINE Project)

    Article • Systematic Reviews, November 2020, Springer Science + Business Media

    Allan R Thomsen

  21. A Systematic, Unbiased Mapping of CD8+ and CD4+ T Cell Epitopes in Yellow Fever Vaccinees

    Article • Frontiers in Immunology, August 2020, Frontiers

    Allan R Thomsen

  22. Effector CD8 T Cell-Dependent Zika Virus Control in the CNS: A Matter of Time and Numbers

    Article • Frontiers in Immunology, August 2020, Frontiers

    Allan R Thomsen

  23. A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice

    Article • Vaccines, July 2020, MDPI AG

    Allan R Thomsen

  24. MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans

    Article • Science Translational Medicine, June 2020, American Association for the Advancement of Science

    Allan R Thomsen

  25. Harnessing Cross-Reactive CD8+TRMCells for Long-Standing Protection Against Influenza A Virus

    Article • Viral Immunology, April 2020, Mary Ann Liebert Inc

    Allan R Thomsen

  26. Pathogenic CD8+ Epidermis-Resident Memory T Cells Displace Dendritic Epidermal T Cells in Allergic Dermatitis

    Article • Journal of Investigative Dermatology, April 2020, Elsevier

    Allan R Thomsen

  27. Local Antigen Encounter Is Essential for Establishing Persistent CD8+ T-Cell Memory in the CNS

    Article • Frontiers in Immunology, March 2019, Frontiers

    Allan R Thomsen

  28. Chemokine Expression in Murine RPE/Choroid in Response to Systemic Viral Infection and Elevated Levels of Circulating Interferon-γ

    Article • Investigative Ophthalmology & Visual Science, January 2019, Association for Research in Vision and Ophthalmology (ARVO)

    Allan R Thomsen

  29. A ‘Furry-Tale’ of Zika Virus Infection: What Have We Learned from Animal Models?

    Article • Viruses, January 2019, MDPI AG

    Allan R Thomsen

  30. Commentary: Endogenous glucocorticoids control host resistance to viral infection through  tissue-specific regulation of PD-1 expression on NK cells

    Article • Cellular and Molecular Immunology, December 2018, Springer Science + Business Media

    Allan R Thomsen

  31. Lipocalin-2 Functions as Inhibitor of Innate Resistance to Mycobacterium tuberculosis

    Article • Frontiers in Immunology, November 2018, Frontiers

    Allan R Thomsen

  32. Replication deficient human adenovirus vector serotype 19a/64: Immunogenicity in mice and female cynomolgus macaques

    Article • Vaccine, October 2018, Elsevier

    Allan R Thomsen

  33. Non-redundant ISGF3 Components Promote NK Cell Survival in an Auto-regulatory Manner during Viral Infection

    Article • Cell Reports, August 2018, Elsevier

    Allan R Thomsen

  34. Analysis of adenovirus-induced immunity to infection with Listeria monocytogenes : Fading protection coincides with declining CD8 T cell numbers and phenotypic changes

    Article • Vaccine, May 2018, Elsevier

    Allan R Thomsen

  35. A New In Vivo Model to Study Protective Immunity to Zika Virus Infection in Mice With Intact Type I Interferon Signaling

    Article • Frontiers in Immunology, March 2018, Frontiers

    Allan R Thomsen

  36. Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant

    Article • Frontiers in Immunology, January 2018, Frontiers

    Allan R Thomsen

  37. SSI 2017 44th Annual Meeting of the Scandinavian Society of Immunology Stockholm, Sweden 17-20 October 2017

    Article • Scandinavian Journal of Immunology, September 2017, Wiley

    Allan R Thomsen

  38. A new vaccination strategy to trigger specific CD4 T-cell response in chronic viral infection

    Article • Cellular and Molecular Immunology, May 2017, Springer Science + Business Media

    Allan R Thomsen

  39. Broadening CD4+ and CD8+ T Cell Responses against Hepatitis C Virus by Vaccination with NS3 Overlapping Peptide Panels in Cross-Priming Liposomes

    Article • Journal of Virology, April 2017, ASM Journals

    Allan R Thomsen

  40. Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination

    Article • Scientific Reports, April 2017, Springer Science + Business Media

    Allan R Thomsen

  41. Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication

    Article • EBioMedicine, April 2017, Elsevier

    Allan R Thomsen

  42. The combined action of mast cell chymase, tryptase and carboxypeptidase A3 protects against melanoma colonization of the lung

    Article • Oncotarget, February 2017, Impact Journals, LLC

    Allan R Thomsen

  43. EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia–like B-cell malignancies

    Article • Blood, December 2016, American Society of Hematology

    Allan R Thomsen

  44. Early life vaccination: Generation of adult-quality memory CD8+ T cells in infant mice using non-replicating adenoviral vectors

    Article • Scientific Reports, December 2016, Springer Science + Business Media

    Allan R Thomsen

  45. Rapid allergen-induced interleukin-17 and interferon-γ secretion by skin-resident memory CD8+T cells

    Article • Contact Dermatitis, November 2016, Wiley

    Allan R Thomsen

  46. PB1 as a potential target for increasing the breadth of T-cell mediated immunity to Influenza A

    Article • Scientific Reports, October 2016, Springer Science + Business Media

    Allan R Thomsen

  47. Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice

    Article • PLoS Neglected Tropical Diseases, February 2016, PLOS

    Allan R Thomsen

  48. Vaccine Targeting of Subdominant CD8+T Cell Epitopes Increases the Breadth of the T Cell Response upon Viral Challenge, but May Impair Immediate Virus Control

    Article • The Journal of Immunology, February 2016, The American Association of Immunologists

    Allan R Thomsen

  49. Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus

    Article • Scientific Reports, February 2016, Springer Science + Business Media

    Allan R Thomsen

  50. An innate antiviral pathway acting before interferons at epithelial surfaces

    Article • Nature Immunology, November 2015, Springer Science + Business Media

    Allan R Thomsen

  51. Targeting of Non-Dominant Antigens as a Vaccine Strategy to Broaden T-Cell Responses during Chronic Viral Infection

    Article • PLOS One, February 2015, PLOS

    Allan R Thomsen

  52. CD8+T Cells Complement Antibodies in Protecting against Yellow Fever Virus

    Article • The Journal of Immunology, December 2014, The American Association of Immunologists

    Allan R Thomsen

  53. Co-Expression of Tumor Antigen and Interleukin-2 From an Adenoviral Vector Augments the Efficiency of Therapeutic Tumor Vaccination

    Article • Molecular Therapy, December 2014, Elsevier

    Allan R Thomsen

  54. Suppressors of Cytokine Signaling 1 and 3 Are Upregulated in Brain Resident Cells in Response to Virus-Induced Inflammation of the Central Nervous System via at Least Two Distinctive Pathways

    Article • Journal of Virology, September 2014, ASM Journals

    Allan R Thomsen

  55. Midline 1 directs lytic granule exocytosis and cytotoxicity of mouse killer T cells

    Article • European Journal of Immunology, August 2014, Wiley

    Allan R Thomsen

  56. Epicutaneous exposure to nickel induces nickel allergy in mice via a MyD88‐dependent and interleukin‐1‐dependent pathway

    Article • Contact Dermatitis, July 2014, Wiley

    Dr Jacob P Thyssen, Allan R Thomsen

  57. Priming of CD8 T Cells by Adenoviral Vectors Is Critically Dependent on B7 and Dendritic Cells but Only Partially Dependent on CD28 Ligation on CD8 T Cells

    Article • The Journal of Immunology, June 2014, The American Association of Immunologists

    Allan R Thomsen

  58. IFNγand Perforin Cooperate to Control Infection and Prevent Fatal Pathology During Persistent Gammaherpesvirus Infection in Mice

    Article • Scandinavian Journal of Immunology, May 2014, Wiley

    Allan R Thomsen

  59. Quantification of B16 Melanoma Cells in Lungs Using Triplex Q-PCR - A New Approach to Evaluate Melanoma Cell Metastasis and Tumor Control

    Article • PLOS One, January 2014, PLOS

    Allan R Thomsen

  60. Adenovirus-Based Vaccine against Listeria monocytogenes: Extending the Concept of Invariant Chain Linkage

    Article • The Journal of Immunology, September 2013, The American Association of Immunologists

    Allan R Thomsen

  61. Comparison of Vaccine-Induced Effector CD8 T Cell Responses Directed against Self- and Non-Self-Tumor Antigens: Implications for Cancer Immunotherapy

    Article • The Journal of Immunology, September 2013, The American Association of Immunologists

    Allan R Thomsen

  62. The Availability of a Functional Tumor Targeting T-Cell Repertoire Determines the Anti-Tumor Efficiency of Combination Therapy with Anti-CTLA-4 and Anti-4-1BB Antibodies

    Article • PLOS One, June 2013, PLOS

    Allan R Thomsen

  63. Qualitative and Quantitative Analysis of Adenovirus Type 5 Vector-Induced Memory CD8 T Cells: Not as Bad as Their Reputation

    Article • Journal of Virology, March 2013, ASM Journals

    Allan R Thomsen

  64. Experimental Hyperactivity of the Endolymphatic Sac

    Article • Audiology and Neurotology, January 2013, Karger Publishers

    Allan R Thomsen

  65. Increased Immunogenicity and Protective Efficacy of Influenza M2e Fused to a Tetramerizing Protein

    Article • PLOS One, October 2012, PLOS

    Allan R Thomsen

  66. MyD88 Drives the IFN-  Response to Lactobacillus acidophilus in Dendritic Cells through a Mechanism Involving IRF1, IRF3, and IRF7

    Article • The Journal of Immunology, August 2012, The American Association of Immunologists

    Allan R Thomsen

  67. Differential Impact of Interferon Regulatory Factor 7 in Initiation of the Type I Interferon Response in the Lymphocytic Choriomeningitis Virus-Infected Central Nervous System versus the Periphery

    Article • Journal of Virology, April 2012, ASM Journals

    Professor Peter Liljeström, Allan R Thomsen

  68. Pre-Existing Vector Immunity Does Not Prevent Replication Deficient Adenovirus from Inducing Efficient CD8 T-Cell Memory and Recall Responses

    Article • PLOS One, April 2012, PLOS

    Allan R Thomsen

  69. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice

    Article • Journal of Clinical Investigation, April 2012, American Society for Clinical Investigation

    Allan R Thomsen

  70. Sensing of RNA Viruses: a Review of Innate Immune Receptors Involved in Recognizing RNA Virus Invasion

    Article • Journal of Virology, January 2012, ASM Journals

    Allan R Thomsen

  71. Vaccination against Lymphocytic Choriomeningitis Virus Infection in MHC Class II-Deficient Mice

    Article • The Journal of Immunology, February 2011, The American Association of Immunologists

    Allan R Thomsen

  72. CXCL10/CXCR3 signaling in glia cells differentially affects NMDA-induced cell death in CA and DG neurons of the mouse hippocampus

    Article • Hippocampus, January 2011, Wiley

    Allan R Thomsen

  73. Enhanced and Sustained CD8+ T Cell Responses with an Adenoviral Vector-Based Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant Chain

    Article • The Journal of Immunology, January 2011, The American Association of Immunologists

    Allan R Thomsen

  74. Adenoviral vaccination combined with CD40 stimulation and CTLA-4 blockage can lead to complete tumor regression in a murine melanoma model

    Article • Vaccine, September 2010, Elsevier

    Allan R Thomsen

  75. The Role of CD80/CD86 in Generation and Maintenance of Functional Virus-Specific CD8+ T Cells in Mice Infected with Lymphocytic Choriomeningitis Virus

    Article • The Journal of Immunology, July 2010, The American Association of Immunologists

    Allan R Thomsen

  76. The murine gammaherpesvirus-68 chemokine-binding protein M3 inhibits experimental autoimmune encephalomyelitis

    Article • Journal of Neuroimmunology, July 2010, Elsevier

    Allan R Thomsen

  77. Quality of the Transgene-Specific CD8+ T Cell Response Induced by Adenoviral Vector Immunization Is Critically Influenced by Virus Dose and Route of Vaccination

    Article • The Journal of Immunology, March 2010, The American Association of Immunologists

    Allan R Thomsen

  78. In Vitro Propagation and Dynamics of T cells from Skin Biopsies by Methods Using Interleukins-2 and -4 or Anti-CD3/CD28 Antibody-coated Microbeads

    Article • Acta Dermato-Venereologica, January 2010, Acta Dermato-Venereologica

    Allan R Thomsen

  79. Interleukin-6 autoantibodies are involved in the pathogenesis of a subset of type 2 diabetes

    Article • Journal of Endocrinology, December 2009, Bioscientifica

    Allan R Thomsen

  80. Expression and Role of CXCL10 during the Encephalitic Stage of Experimental and Clinical African Trypanosomiasis

    Article • The Journal of Infectious Diseases, November 2009, Oxford University Press (OUP)

    Allan R Thomsen

  81. Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load

    Article • Vaccine, November 2009, Elsevier

    Allan R Thomsen

  82. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4+T-cell-independent CD8+T-cell-mediated tumor control

    Article • European Journal of Immunology, October 2009, Wiley

    Allan R Thomsen

  83. CXCR3 Directs Antigen-Specific Effector CD4+ T Cell Migration to the Lung During Parainfluenza Virus Infection

    Article • The Journal of Immunology, September 2009, The American Association of Immunologists

    Allan R Thomsen

  84. CONCANAVALIN A-INDUCED ACTIVATION OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS MEMORY LYMPHOCYTES INTO SPECIFICALLY CYTOTOXIC T CELLS

    Article • Acta Pathologica Microbiologica Scandinavica Section C Immunology, August 2009, Wiley

    Allan R Thomsen

  85. Co-ordinating innate and adaptive immunity to viral infection: mobility is the key

    Article • Apmis, May 2009, Wiley

    Allan R Thomsen

  86. Host-microbe relations

    Article • Apmis, May 2009, Wiley

    Allan R Thomsen

  87. CD4 and CD8 T Cell Responses to the M. tuberculosis Ag85B-TB10.4 Promoted by Adjuvanted Subunit, Adenovector or Heterologous Prime Boost Vaccination

    Article • PLOS One, April 2009, PLOS

    Allan R Thomsen

  88. Fusion of a viral antigen to invariant chain leads to augmented T-cell immunity and improved protection in gene-gun DNA-vaccinated mice

    Article • Journal of General Virology, February 2009, Society for General Microbiology

    Allan R Thomsen

  89. T-cell intrinsic expression of MyD88 is required for sustained expansion of the virus-specific CD8+ T-cell population in LCMV-infected mice

    Article • Journal of General Virology, February 2009, Society for General Microbiology

    Allan R Thomsen

  90. Fulminant Lymphocytic Choriomeningitis Virus-Induced Inflammation of the CNS Involves a Cytokine-Chemokine-Cytokine-Chemokine Cascade

    Article • The Journal of Immunology, January 2009, The American Association of Immunologists

    Allan R Thomsen

  91. TLR2 and TLR9 Synergistically Control Herpes Simplex Virus Infection in the Brain

    Article • The Journal of Immunology, December 2008, The American Association of Immunologists

    Allan R Thomsen

  92. TCR Down-Regulation Controls Virus-Specific CD8+ T Cell Responses

    Article • The Journal of Immunology, November 2008, The American Association of Immunologists

    Allan R Thomsen

  93. Lymphocytic Choriomeningitis Virus-Induced Central Nervous System Disease: a Model for Studying the Role of Chemokines in Regulating the Acute Antiviral CD8+ T-Cell Response in an Immune-Privileged Organ

    Article • Journal of Virology, September 2008, ASM Journals

    Allan R Thomsen

  94. Delayed Contraction of the CD8+ T Cell Response toward Lymphocytic Choriomeningitis Virus Infection in Mice Lacking Serglycin

    Article • The Journal of Immunology, July 2008, The American Association of Immunologists

    Allan R Thomsen

  95. Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation

    Article • Clinical & Experimental Immunology, June 2008, Wiley

    Allan R Thomsen

  96. MHC Class II-Associated Invariant Chain Linkage of Antigen Dramatically Improves Cell-Mediated Immunity Induced by Adenovirus Vaccines

    Article • The Journal of Immunology, February 2008, The American Association of Immunologists

    Allan R Thomsen

  97. An Important Role for Type III Interferon (IFN- /IL-28) in TLR-Induced Antiviral Activity

    Article • The Journal of Immunology, February 2008, The American Association of Immunologists

    Allan R Thomsen

  98. Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation

    Article • International Immunopharmacology, December 2007, Elsevier

    Allan R Thomsen

  99. Virus-based immunotherapy of cancer: what do we know and where are we going?

    Article • Apmis, November 2007, Wiley

    Allan R Thomsen

  100. CCR5 and CXCR3 Are Dispensable for Liver Infiltration, but CCR5 Protects against Virus-Induced T-Cell-Mediated Hepatic Steatosis

    Article • Journal of Virology, July 2007, ASM Journals

    Allan R Thomsen

  101. Rapid and sustained CD4+ T-cell-independent immunity from adenovirus-encoded vaccine antigens

    Article • Journal of General Virology, June 2007, Society for General Microbiology

    Allan R Thomsen

  102. Agonistic Anti-CD40 Antibody Profoundly Suppresses the Immune Response to Infection with Lymphocytic Choriomeningitis Virus

    Article • The Journal of Immunology, January 2007, The American Association of Immunologists

    Allan R Thomsen

  103. Functional epistasis on a common MHC haplotype associated with multiple sclerosis

    Article • Nature, September 2006, Springer Science + Business Media

    Allan R Thomsen

  104. MEK kinase 1 is a negative regulator of virus-specific CD8+ T cells

    Article • European Journal of Immunology, August 2006, Wiley

    Allan R Thomsen

  105. Corrigendum to “Interleukin-21 mRNA expression during virus infections” [Cytokine 33;2006:41–5]

    Article • Cytokine, July 2006, Elsevier

    Allan R Thomsen

  106. Lambda Interferon (IFN-λ), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo

    Article • Journal of Virology, May 2006, ASM Journals

    Allan R Thomsen

  107. CXC chemokine receptor 3 expression increases the disease-inducing potential of CD4+ CD25− T cells in adoptive transfer colitis

    Article • Inflammatory Bowel Diseases, May 2006, Oxford University Press (OUP)

    Allan R Thomsen

  108. Role of Very Late Antigen-1 in T-cell-Mediated Immunity to Systemic Viral Infection

    Article • Scandinavian Journal of Immunology, April 2006, Wiley

    Allan R Thomsen

  109. CXCL10 Is the Key Ligand for CXCR3 on CD8+ Effector T Cells Involved in Immune Surveillance of the Lymphocytic Choriomeningitis Virus-Infected Central Nervous System

    Article • The Journal of Immunology, March 2006, The American Association of Immunologists

    Allan R Thomsen

  110. Perforin-Deficient CD8+ T Cells Mediate Fatal Lymphocytic Choriomeningitis despite Impaired Cytokine Production

    Article • Journal of Virology, February 2006, ASM Journals

    Allan R Thomsen

  111. Interleukin-21 mRNA expression during virus infections

    Article • Cytokine, January 2006, Elsevier

    Allan R Thomsen

  112. Stem cells

    Article • Apmis, November 2005, Wiley

    Allan R Thomsen

  113. Effect of the CTL proliferation program on virus dynamics

    Article • International Immunology, August 2005, Oxford University Press (OUP)

    Allan R Thomsen

  114. Impaired Virus Control and Severe CD8+ T-Cell-Mediated Immunopathology in Chimeric Mice Deficient in Gamma Interferon Receptor Expression on both Parenchymal and Hematopoietic Cells

    Article • Journal of Virology, August 2005, ASM Journals

    Allan R Thomsen

  115. Opposing Effects of CXCR3 and CCR5 Deficiency on CD8+ T Cell-Mediated Inflammation in the Central Nervous System of Virus-Infected Mice

    Article • The Journal of Immunology, July 2005, The American Association of Immunologists

    Allan R Thomsen

  116. Does programmed CTL proliferation optimize virus control?

    Article • Trends in Immunology, June 2005, Elsevier

    Allan R Thomsen

  117. Single-Epitope DNA Vaccination Prevents Exhaustion and Facilitates a Broad Antiviral CD8 + T Cell Response during Chronic Viral Infection

    Article • The Journal of Immunology, November 2004, The American Association of Immunologists

    Allan R Thomsen

  118. Gene-gun DNA vaccination aggravates respiratory syncytial virus-induced pneumonitis

    Article • Journal of General Virology, October 2004, Society for General Microbiology

    Allan R Thomsen

  119. Cytokine production by virus-specific CD8+ T cells varies with activation state and localization, but not with TCR avidity

    Article • Journal of General Virology, June 2004, Society for General Microbiology

    Allan R Thomsen

  120. Efficient T-Cell Surveillance of the CNS Requires Expression of the CXC Chemokine Receptor 3

    Article • Journal of Neuroscience, May 2004, Society for Neuroscience

    Allan R Thomsen

  121. Perforin and IFN-γ do not significantly regulate the virus-specific CD8+ T?cell response in the absence of antiviral effector activity

    Article • European Journal of Immunology, May 2004, Wiley

    Allan R Thomsen

  122. Knocking out IL-6 by vaccination

    Article • European Journal of Immunology, January 2004, Wiley

    Allan R Thomsen

  123. Role of Macrophage Inflammatory Protein-1α in T-Cell-Mediated Immunity to Viral Infection

    Article • Journal of Virology, November 2003, ASM Journals

    Allan R Thomsen

  124. Deficient CD4+ T Cell Priming and Regression of CD8+ T Cell Functionality in Virus-Infected Mice Lacking a Normal B Cell Compartment

    Article • The Journal of Immunology, October 2003, The American Association of Immunologists

    Allan R Thomsen

  125. Expression and Functional Importance of Collagen-Binding Integrins,  1 1 and  2 1, on Virus-Activated T Cells

    Article • The Journal of Immunology, September 2003, The American Association of Immunologists

    Allan R Thomsen

  126. The Virus-Encoded Chemokine vMIP-II Inhibits Virus-Induced Tc1-Driven Inflammation

    Article • Journal of Virology, July 2003, ASM Journals

    Allan R Thomsen

  127. Incomplete effector/memory differentiation of antigen-primed CD8+ T cells in gene gun DNA-vaccinated mice

    Article • European Journal of Immunology, July 2003, Wiley

    Allan R Thomsen

  128. Regulation of T cell migration during viral infection: role of adhesion molecules and chemokines

    Article • Immunology Letters, January 2003, Elsevier

    Allan R Thomsen

  129. High numbers of IL-2-producing CD8+ T cells during viral infection: correlation with stable memory development

    Article • Journal of General Virology, September 2002, Society for General Microbiology

    Allan R Thomsen

  130. Role of CD28 co-stimulation in generation and maintenance of virus-specific T cells

    Article • International Immunology, July 2002, Oxford University Press (OUP)

    Allan R Thomsen

  131. The importance of lytic and nonlytic immune responses in viral infections

    Article • Trends in Immunology, April 2002, Elsevier

    Allan R Thomsen

  132. The role of CC chemokine receptor 5 in antiviral immunity

    Article • Blood, February 2002, American Society of Hematology

    Allan R Thomsen

  133. CD11b expression as a marker to distinguish between recently activated effector CD8+ T cells and memory cells

    Article • International Immunology, April 2001, Oxford University Press (OUP)

    Allan R Thomsen

  134. Depletion of CD4+ T Cells Precipitates Immunopathology in Immunodeficient Mice Infected with a Noncytocidal Virus

    Article • The Journal of Immunology, March 2001, The American Association of Immunologists

    Allan R Thomsen

  135. Persistent Virus Infection despite Chronic Cytotoxic T-Lymphocyte Activation in Gamma Interferon-Deficient Mice Infected with Lymphocytic Choriomeningitis Virus

    Article • Journal of Virology, November 2000, ASM Journals

    Allan R Thomsen

  136. Host factors influencing viral persistence

    Article • Philosophical Transactions of the Royal Society B Biological Sciences, August 2000, Royal Society Publishing

    Allan R Thomsen

  137. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene

    Article • Clinical & Experimental Immunology, August 2000, Wiley

    Allan R Thomsen

  138. CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection

    Article • European Journal of Immunology, July 2000, Wiley

    Allan R Thomsen

  139. Role of CD40 Ligand and CD28 in Induction and Maintenance of Antiviral CD8+ Effector T Cell Responses

    Article • The Journal of Immunology, April 2000, The American Association of Immunologists

    Allan R Thomsen

  140. A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment

    Article • Philosophical Transactions of the Royal Society B Biological Sciences, March 2000, Royal Society Publishing

    Allan R Thomsen

  141. Cytokine vaccination: neutralising IL-1α autoantibodies induced by immunisation with homologous IL-1α

    Article • Journal of Immunological Methods, March 2000, Elsevier

    Allan R Thomsen

  142. CD4+ T cell-mediated protection against a lethal outcome of systemic infection with vesicular stomatitis virus requires CD40 ligand expression, but not IFN-γ or IL-4

    Article • International Immunology, December 1999, Oxford University Press (OUP)

    Allan R Thomsen

  143. Virus-induced non-specific signals cause cell cycle progression of primed CD8+ T cells but do not induce cell differentiation

    Article • International Immunology, September 1999, Oxford University Press (OUP)

    Allan R Thomsen

  144. Soluble tumour necrosis factor (TNF)-receptor levels in serum as markers of anti-viral host reactivity

    Article • Clinical & Experimental Immunology, May 1999, Wiley

    Allan R Thomsen

  145. Role of interferon-γ in the pathogenesis of LCMV-induced meningitis: unimpaired leucocyte recruitment, but deficient macrophage activation in interferon-γ knock-out mice

    Article • Journal of Neuroimmunology, June 1998, Elsevier

    Allan R Thomsen

  146. Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus

    Article • International Immunology, November 1997, Oxford University Press (OUP)

    Allan R Thomsen

  147. Sensitization to Lipopolysaccharide in Mice with Asymptomatic Viral Infection: Role of T Cell‐Dependent Production of Interferon–γ

    Article • The Journal of Infectious Diseases, July 1997, Oxford University Press (OUP)

    Allan R Thomsen

  148. The Susceptibility to Cytotoxic T Lymphocyte Mediated Lysis of Chemically Induced Sarcomas from Immunodeficient and Normal Mice

    Article • Scandinavian Journal of Immunology, January 1997, Wiley

    Allan R Thomsen

  149. Characterization of virus-primed CD8+ T cells with a type 1 cytokine profile

    Article • International Immunology, January 1996, Oxford University Press (OUP)

    Allan R Thomsen

  150. Virus-induced polyclonal T cell activation is followed by apoptosis: partitioning of CD8+ T cells based on α4 integrin expression

    Article • International Immunology, January 1996, Oxford University Press (OUP)

    Allan R Thomsen

  151. Virus-activated T cells regulate expression of adhesion molecules on endothelial cells in sites of infection

    Article • Journal of Neuroimmunology, October 1995, Elsevier

    Allan R Thomsen

  152. Lymphocytic Choriomeningitis Virus Infection is Associated with Long-Standing Perturbation of LFA-1 Expression on CD8+ T Cells

    Article • Scandinavian Journal of Immunology, July 1995, Wiley

    Allan R Thomsen

  153. Analysis of the Capacity to Produce IL-3 in Murine AIDS

    Article • Scandinavian Journal of Immunology, October 1994, Wiley

    Allan R Thomsen

  154. The Role of CD4+ T Cells in Cell-Mediated Immunity to LCM V: Studies in MHC Class I and Class II Deficient Mice

    Article • Scandinavian Journal of Immunology, October 1994, Wiley

    Allan R Thomsen

  155. T-Cell Responsiveness to LCMV Segregates as a Single Locus in Crosses between BALB/cA and C.B-17 Mice. Evidence for Regulation by a Gene Outside the Igh Region

    Article • Scandinavian Journal of Immunology, September 1993, Wiley

    Allan R Thomsen

  156. Breakdown of blood-brain barrier function in the murine lymphocytic choriomeningitis virus infection mediated by virus-specific CD8+ T cells

    Article • Journal of Neuroimmunology, February 1991, Elsevier

    Allan R Thomsen

  157. Class I gene regulation of haplotype preference may influence antiviral immunity in vivo

    Article • Cellular Immunology, September 1989, Elsevier

    Allan R Thomsen

  158. The Combination of Major Histocompatibility Complex (MHC) and Non-MHC Genes Influences Murine Lymphocytic Choriomeningitis Virus Pathogenesis

    Article • Scandinavian Journal of Immunology, May 1989, Wiley

    Allan R Thomsen

  159. Different Tc Response Profiles are Associated with Survival in the Murine Lymphocytic Choriomeningitis Virus Infection

    Article • Scandinavian Journal of Immunology, June 1987, Wiley

    Allan R Thomsen

  160. T-Cell Effector Function and Unresponsiveness in the Murine Lymphocytic Choriomeningitis Virus Infection.

    Article • Scandinavian Journal of Immunology, August 1986, Wiley

    Allan R Thomsen

  161. T-Cell Effector Function and Unresponsiveness in the Murine Lymphocytic Choriomeningitis Virus Infection.

    Article • Scandinavian Journal of Immunology, August 1986, Wiley

    Allan R Thomsen

  162. The dual role of lymphocytic choriomeningitis virus-specific antibodies

    Article • Medical Microbiology and Immunology, May 1986, Springer Science + Business Media

    Allan R Thomsen

  163. The effect of lymphocytic choriomeningitis virus-induced suppression of the delayed-type hypersensitivity reaction on virus clearance and pathogenicity

    Article • Medical Microbiology and Immunology, May 1986, Springer Science + Business Media

    Allan R Thomsen

  164. High-Dose Survival in the Lymphocytic Choriomeningitis Virus Infection Is Accompanied by Suppressed DTH but Unaffected T-Cell Cytotoxicity

    Article • Scandinavian Journal of Immunology, January 1985, Wiley

    Allan R Thomsen

  165. Studies on the Role of Mononuclear Phagocytes in Resistance to Acute Lymphocytic Choriomeningitis Virus Infection

    Article • Scandinavian Journal of Immunology, October 1983, Wiley

    Allan R Thomsen

  166. Virus Elimination in Acute Lymphocytic Choriomeningitis Virus Infection Correlation with Virus-Specific Delayed-Type Hypersensitivity rather than Cytotoxicity

    Article • Scandinavian Journal of Immunology, June 1983, Wiley

    Allan R Thomsen

  167. Fatal Meningitis following Lymphocytic Choriomeningitis Virus Infection Reflects Delayed-Type Hypersensitivity Rather than Cytotoxicity

    Article • Scandinavian Journal of Immunology, February 1983, Wiley

    Allan R Thomsen

  168. Concanavalin A-mediated in Vitro Activation of a Secondary Cytotoxic T-Cell Response in Virus-primed Splenocytes

    Article • Scandinavian Journal of Immunology, August 1980, Wiley

    Allan R Thomsen